Clinical Trial Update: Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer [NA]

View source ↗

Summary

A pilot study evaluating a fluorescence endoscopic device for sentinel lymph node mapping in lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Novel Fluorescence Endoscopic Device

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Lung Cancer | NA | Status: WITHDRAWN